World Journal of Oncology, ISSN 1920-4531 print, 1920-454X online, Open Access
Article copyright, the authors; Journal compilation copyright, World J Oncol and Elmer Press Inc
Journal website http://www.wjon.org

Original Article

Volume 8, Number 4, August 2017, pages 110-116

Role of Taxanes in Triple-Negative Breast Cancer: A Study From Tertiary Cancer Center in South India

Figures

Figure 1.
Figure 1. DFS in patients with TNBC (n = 178).
Figure 2.
Figure 2. OS in patients with TNBC (n = 178).
Figure 3.
Figure 3. DFS comparison of anthracycline vs. anthracycline + taxane-based regimen.
Figure 4.
Figure 4. OS comparison of anthracycline vs. anthracycline + taxane-based regimen.

Table

Table 1. Patient Characteristic and Treatment Received
 
n = 237%
NACT: neoadjuvant chemotherapy.
Median age (years)45 (range 22 - 85)
Menopausal status
  Premenopausal13858
  Postmenopausal9942
Stage
  I62.5
  II9841.3
  III11247.3
  IV218.9
Histology
  Invasive ductal carcinoma22996.6
  Metaplastic52.1
  Medullary31.3
Grade
  I00
  II3313.9
  III20486.1
Surgery for stage I-III
  Yes20394.0
  No136.0
Chemotherapy (NACT or adjuvant)
  Yes17887.7
  No2512.3
Regimen used
  Anthracycline-based8547.8
  Anthracycline + taxane-based9352.2
Pattern of metastasis (n = 70; out of 178 patients evaluated)
  Loco-regional2738.6
  Lung2231.4
  Liver1420.0
  Brain811.4
  Bone2332.9